Want to see DE:TLX full AI Analyst Report?
Top Page
Talanx AG
(XETRA:TLX)
Select Model
Select Model
Rating:74Outperform
Price Target:
€128.00
▲(8.11% Upside)
Action:Upgraded
Date:03/20/26
The score is driven primarily by strong financial performance (improving earnings/returns, declining leverage, and robust cash generation). Valuation is supportive with a moderate P/E and a ~2.5% dividend yield. Technicals are only moderately positive, with the price still below longer-term moving averages and an elevated Stochastic suggesting momentum may be somewhat stretched.
Positive Factors
Cash generation
Talanx's consistently large operating cash flows and €7.92B free cash flow in 2025 indicate strong cash conversion and earnings quality. Durable cash generation supports reserves, reinsurance capacity, organic growth, and shareholder returns, reducing reliance on external funding across business cycles.
Negative Factors
Revenue and profit volatility
Volatile top-line and a profitability step-down in 2025 reduce earnings predictability. For an insurer, irregular premium recognition, reserving variability or large claims years can materially affect margins and capital needs, making multi-period planning and dividend stability harder.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Talanx's consistently large operating cash flows and €7.92B free cash flow in 2025 indicate strong cash conversion and earnings quality. Durable cash generation supports reserves, reinsurance capacity, organic growth, and shareholder returns, reducing reliance on external funding across business cycles.
Read all positive factors
Talanx AG (TLX) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€29.53B
Dividend Yield2.37%
Average Volume (3M)98.76K
Price to Earnings (P/E)11.1
Beta (1Y)0.92
Revenue Growth3.40%
EPS Growth31.91%
CountryDE
Employees29,357
SectorGeneral
Sector StrengthN/A
IndustryInsurance - Diversified
Share Statistics
EPS (TTM)10.27
Shares Outstanding258,229,000
10 Day Avg. Volume108,935
30 Day Avg. Volume98,760
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)2.18
Price to Sales (P/S)0.51
P/FCF Ratio3.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€130.75Price Target Upside10.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)10.81
Revenue Forecast (FY)€51.86B
Talanx AG Business Overview & Revenue Model
Company Description
Talanx AG operates internationally, delivering a comprehensive suite of insurance and reinsurance services. Its extensive direct insurance portfolio encompasses life, casualty, liability, and motor coverage, alongside a wide array of property-rela...
How the Company Makes Money
Talanx makes money primarily by underwriting insurance and reinsurance risks and investing the premiums it collects. (1) Insurance underwriting income: In its primary insurance businesses (property & casualty, life, and health), the company sells ...
Talanx AG Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
82
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.56B | 57.27B | 25.58B | 19.23B | 18.73B | 43.13B |
| Gross Profit | 53.56B | 57.27B | 27.40B | 20.35B | 19.66B | 33.69B |
| EBITDA | 5.64B | 5.42B | 5.11B | 3.22B | 2.91B | 2.67B |
| Net Income | 2.65B | 2.48B | 1.98B | 1.58B | 706.00M | 1.01B |
Balance Sheet | ||||||
| Total Assets | 183.70M | 193.71B | 180.42B | 168.53B | 193.13B | 197.52B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 5.26B | 123.34B | 5.10B | 95.53B | 106.21B |
| Total Debt | 0.00 | 8.48B | 8.90B | 9.11B | 9.78B | 7.73B |
| Total Liabilities | 161.50M | 172.82B | 161.92B | 151.73B | 180.54B | 179.58B |
| Stockholders Equity | 14.30M | 13.47B | 11.66B | 10.45B | 8.64B | 10.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.92B | 8.43B | 7.63B | 5.77B | 8.38B |
| Operating Cash Flow | 0.00 | 8.37B | 8.43B | 8.10B | 5.97B | 10.05B |
| Investing Cash Flow | 0.00 | -5.76B | -6.79B | -5.03B | -6.86B | -10.06B |
| Financing Cash Flow | 0.00 | -2.02B | -1.58B | -1.49B | 521.00M | 428.00M |
Talanx AG Technical Analysis
Positive
118.40
Price Trends
105.66
Positive
105.28
Positive
105.88
Positive
Market Momentum
2.31
Negative
79.18
Negative
98.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:TLX, the sentiment is Positive. The current price of 118.4 is above the 20-day moving average (MA) of 105.78, above the 50-day MA of 105.66, and above the 200-day MA of 105.88, indicating a bullish trend. The MACD of 2.31 indicates Negative momentum. The RSI at 79.18 is Negative, neither overbought nor oversold. The STOCH value of 98.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:TLX.
Talanx AG Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €29.53B | 11.10 | 27.86% | 2.37% | 3.40% | 31.91% | |
71 Outperform | €158.98B | 13.46 | 19.58% | 3.94% | ― | ― | |
71 Outperform | €29.45B | 3.21 | 73.88% | 3.37% | -2.57% | 27.56% | |
67 Neutral | €63.03B | 9.56 | 20.64% | 3.56% | -1.59% | 49.39% | |
67 Neutral | €1.39B | 31.48 | 5.08% | 0.12% | -2.67% | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | €1.40B | 11.52 | 2.43% | 4.49% | ― | ― |
* General Sector Average
DE:TLX
Talanx AG
114.40
7.12
6.64%
DE:ALV
Allianz
419.80
85.58
25.61%
DE:HNR1
Hannover Rueck
244.20
-11.51
-4.50%
DE:MUV2
Munich Reinsurance
496.40
-44.95
-8.30%
DE:WUW
Wuestenrot & Wuerttembergische
14.94
1.93
14.87%
DE:NBG6
Nuernberger Beteiligungs AG Class B
121.00
71.05
142.23%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.